|
|
|
|
|
|
Actinium Pharmaceuticals Inc (ATNM)
|
|
1.23 +0.02 (+1.65%)
|
6/22/2017 4:02pm
|
|
Open:
|
1.21
|
Pre. Close:
|
1.21
|
|
High:
|
1.25
|
Low:
|
1.20
|
|
Volume:
|
155,307
|
Market Cap:
|
71.89M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.27 - 1.29
|
1.29 - 1.33
|
|
Low:
|
1.13 - 1.15
|
1.15 - 1.18
|
|
Close:
|
1.18 - 1.22
|
1.22 - 1.28
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-22 4:35:45 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 1.54 One year: 1.75
|
|
Support:
|
Support1: 1.03 Support2: 0.86
|
|
Resistance:
|
Resistance1:
1.32 Resistance2: 1.50
|
|
Pivot:
|
1.33 
|
|
Moving Averages:
|
MA(5): 1.21  MA(20): 1.35
MA(100): 1.40 MA(250): 1.37
|
|
MACD:
|
MACD(12,26):
-0.06 Signal(12,26,9): -0.04
|
|
%K %D:
|
%K(14,3): 40.43 %D(3): 39.24
|
|
RSI:
|
RSI(14): 41.60
|
|
52-Week:
|
High: 2.15
Low: 0.86 Change(%): -30.5
|
|
Average Vol(K):
|
3-Month: 703
10-Days 491
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ATNM has closed above bottom band by 32.7%. Bollinger Bands are 106.3% wider than normal. The large width of the bands suggest high volatility as compared to ATNM's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Tue, 23 May 2017 11:33:23 GMT
Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International ...
Mon, 12 Jun 2017 10:52:30 GMT
Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal ...
Mon, 19 Jun 2017 10:41:15 GMT
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) Appoints Sandesh Seth As Its New ...
Mon, 19 Dec 2016 12:02:11 GMT
Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of ...
Wed, 17 May 2017 11:00:54 GMT
Actinium Pharmaceuticals Announces Appointment of Hematology Expert Dr ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
